Skip to main content

Table 2 The pathways involved in differentially expressed genes compared with different time points following AMI

From: Potential biomarkers of acute myocardial infarction based on weighted gene co-expression network analysis

 

Pathways

Q-value (Q < 0.05)

admission versus control group

Natural killer cell mediated cytotoxicity

3.142005e−09

Graft-versus-host disease

5.779472e−07

Antigen processing and presentation

2.997803e−03

Cytosolic DNA-sensing pathway

2.302012e−02

discharge versus control group

Natural killer cell mediated cytotoxicity

8.154634e−10

Graft-versus-host disease

1.164728e−08

Antigen processing and presentation

1.657503e−04

Allograft rejection

2.438676e−02

admission versus 6 months

Oxidative phosphorylation

3.841450e−15

Huntington’s disease

1.570003e−12

Parkinson’s disease

2.462576e−12

Alzheimer’s disease

1.076534e−11

discharge versus 6 months

Parkinson’s disease

4.627948e−16

Oxidative phosphorylation

4.627948e−16

Alzheimer’s disease

9.071314e−15

Huntington’s disease

8.428429e−14